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 （論文内容の要旨）                              
    Unmethylated cytosine-phosphate-guanine oligodeoxynucleotide (CpG ODN), which binds to Toll-like 
receptor 9 (TLR9) and activates antigen-presenting cells (APCs), has been studied as one of the nucleic acid 
drugs to stimulate the innate immunity. Recent advances on DNA nanotechnology have greatly opened the 
potential applications of DNA assemblies for CpG ODN delivery and largely solved two major issues upon the 
application of CpG ODN: degradation by nuclease and delivery to TLR9. However, most DNA nanostructures 
developed so far have complex structures, like DNA dendrimer, so sequences need to be properly designed. On 
the other hand, lack of the cellular recognition/targeting property largely limits the further in vivo application 
because its uptake by immune cells just relies on the concentration and stereochemical structures. These problems 
lead to a high synthetic cost in practical application of CpG ODN. To solve these problems, therefore, the 
applicant developed simple strategies (1) to deliver the CpG ODN by nanostructuration using G-quadruplex just 
introducing several guanines into the sequence of CpG ODN and (2) to modify the DNA nanostructures including 
polypod-like structured nucleic acid and G-quadruplex structured CpG ODN by mannose to increase the delivery 
efficiency of CpG ODN to APCs.  
 
Chapter 1  Development of G-quadruplex Structured CpG ODN for Enhanced Stability and 
Immunoreactivity  
    G-quadruplex (GQ) structure, a stable and naturally existing helical secondary nucleic acid structure, is 
formed by stacking of G-quartets, guanine tetrads tightened by Hoogsteen interaction with coordinating metal 
cations (e.g. Na+, K+). The superior stability of GQ structure shows its potential in application to nucleic acid 
drug delivery. In this study, the applicant designed a CpG ODN with only one G-tract (5 guanines) to construct 
a G-quadruplex structured CpG ODN with precise structural properties and activity to induce potent immune 
responses. Phosphodiester CpG ODN with the same sequence as CpG1668 was selected and G-tract was added 
to the 5′-end [1668(5′-G5)], 3′-end [1668(3′-G5)] or internally within the sequence [1668(mid-G5)]. Circular 
dichroism analysis showed that all the CpG ODN with a G-tract formed parallel GQ structures irrespective of the 
location of the G-tract. In addition, electrophoresis showed GQ structured 1668(5′-G5) formed dimer, whereas 
others remained monomeric GQ structures. Single-stranded or GQ structured CpG ODN was added to TLR9-
positive mouse macrophage-like RAW264.7 cells, and tumor necrosis factor (TNF)-α and interleukin (IL)-6 
release from the cells was measured. GQ structured CpG ODNs induced greater secretion of both TNF-α and IL-
6 than single-stranded CpG ODNs, with the highest secretion from 1668(3′-G5). Cellular uptake study showed 
significantly increased uptake of CpG ODN after GQ structure formation. In addition, 1668(3′-G5) showed a 
slow decomposition in serum than 1668(5′-G5). These results indicated that the G-quadruplex formed by only 
one G-tract was a simple and efficient strategy for the delivery of CpG ODN to immune cells, and that addition 
of G-tract to 3′-end was effective in obtaining monomeric GQ structured CpG ODN with high biological stability 
and high immunostimulatory activity. 
 
Chapter 2  Development of Mannose-modified Nanostructured DNA for Targeted Delivery of CpG ODN 
to Antigen-presenting Cells 
    In our laboratory, the polypod-like structured nucleic acid (polypodna), a DNA nanostructure constructed 
with three or more ODNs, has been developed as a novel delivery system for delivery of CpG ODN and apparent 
enhancement in antitumor effects. However, the lack of cellular recognition property largely limits its further in 
vivo application. Mannose receptor (MR), primarily expressed on the surface of APCs, mediated endocytosis has 
been studied to achieve cell-specific drug delivery. Therefore, the applicant selected a hexapodna, a polypodna 
with six pods, and designed a mannose-modified hexapodna to efficiently deliver CpG ODN to the APCs. The 
modification strategy was to load the mannose-modified CpG1668 (Man-CpG1668) onto the CG sequence-free 
 hexapodna. Firstly, a mannose motif with a 5 carbons linker, which aimed at increasing its interaction with 
receptor, was synthesized by 4 steps. Then, CpG1668 with phosphodiester backbone was successfully modified 
by the mannose motif at 5′-end to give mannose-modified CpG1668 (Man-CpG1668). Man-CpG1668 loaded 
hexapodna (Man-CpG1668/Hexapodna) was prepared by annealing all ODNs in one-pot and was obtained with 
high yield. The melting temperature analysis showed mannose modification hardly changed the thermal stability. 
Man-CpG1668/hexapodna induced greater TNF-α release from TLR9- and MR-positive mouse peritoneal 
macrophages than CpG1668/hexapodna. These results indicate that the mannose-modified hexapodna is suitable 
for the delivery of CpG ODN to TLR9-positive immune cells. 
 
Chapter 3  Development of Mannose-modified G-quadruplex Structured CpG ODN for Targeted 
Delivery to Antigen-presenting Cells 
    In Chapter 1, a simple strategy to enhance not only the stability but the immunostimulatory activity and 
internalization efficiency of CpG ODN was successfully achieved by G-quadruplex structuration. In Chapter 2, 
the immunoreactivity of CpG1668/hexapodna was further enhanced by mannose modification. Based on these 
results, in Chapter 3, to further expand the capability of GQ structured CpG ODN, the applicant attempted to 
construct a mannose-modified GQ structured CpG ODN. Initially, 1668(5′-G5) and 1668(3′-G5) were 
successfully modified at 3′-end [1668(5′-G5, 3′-Man)] and 5′-end [1668(5′-Man, 3′-G5)] separately by the 
mannose motif which was synthesized in Chapter 2. However, these two modified sequences failed to form the 
GQ structure due to the steric hindrance and repulsion from the long hydrophobic linker. Therefore, 1668(5′-G5) 
and 1668(3′-G5) were directly modified by α-D-mannopyranosylphenyl isothiocyanate and they could be 
successfully converted to GQ structures. After mannose modification, 1668(5′-G5, 3′-Man) induced higher 
secretion of TNF-α from mouse peritoneal macrophages than unmodified and mannose modified 1668(5′-Man, 
3′-G5). These results suggested that the immunostimulatory activity of GQ structured CpG ODN could be further 
increased by mannose modification and indicated the higher density of mannose motif might be necessary to 
increase the interaction of CpG ODN with APCs due to 2-fold of mannose in 1668(5′-G5, 3′-Man) than 1668(5′-
Man, 3′-G5). 
 
    As described above, the applicant clarified that the stability, delivery and immunostimulatory activity of 
CpG ODN can be improved by introduction of G-quadruplex structure instead of using other nanocarriers. In 
addition, mannose modification is suitable for enhancement of delivery of CpG ODN loaded nanostructures. The 
results in this study not only reveal the potential in simplification of delivery system for CpG ODN, but also 
provide useful information for antigen-presenting cell-targeted strategy in practical application of CpG ODN. 
 
   
    
  
（続紙 ２ ）                            
 
（論文審査の結果の要旨） 
Unmethylated cytosine-phosphate-guanine oligodeoxynucleotide (CpG ODN), which binds to Toll-like receptor 
9 (TLR9) and activates antigen-presenting cells (APCs), has been studied as one of the nucleic acid drugs to 
stimulate the innate immunity. Recent advances on DNA nanotechnology have greatly opened the potential 
applications of DNA assemblies for CpG ODN delivery and largely solved two major issues upon the application 
of CpG ODN: degradation by nuclease and delivery to TLR9. The applicant developed simple strategies (1) to 
deliver the CpG ODN by nanostructuration using G-quadruplex just introducing several guanines into the sequence 
of CpG ODN and (2) to modify the DNA nanostructures including polypod-like structured nucleic acid and G-
quadruplex structured CpG ODN by mannose to increase the delivery efficiency of CpG ODN to APCs.  
 
Chapter 1  Development of G-quadruplex Structured CpG ODN for Enhanced Stability and 
Immunoreactivity  
    The applicant designed a CpG ODN with only one G-tract (5 guanines) to construct a G-quadruplex (GQ)  
structured CpG ODN with precise structural properties and activity to induce potent immune responses. 
Phosphodiester CpG ODN with the same sequence as CpG1668 was selected and G-tract was added to the 5′-end 
[1668(5′-G5)], 3′-end [1668(3′-G5)] or internally within the sequence [1668(mid-G5)]. Circular dichroism analysis 
showed that all the CpG ODN with a G-tract formed parallel GQ structures irrespective of the location of the G-
tract. In addition, electrophoresis showed GQ structured 1668(5′-G5) formed dimer, whereas others remained 
monomeric GQ structures. Single-stranded or GQ structured CpG ODN was added to TLR9-positive mouse 
macrophage-like RAW264.7 cells, and tumor necrosis factor (TNF)-α and interleukin (IL)-6 release from the cells 
was measured. GQ structured CpG ODNs induced greater secretion of both TNF-α and IL-6 than single-stranded 
CpG ODNs, with the highest secretion from 1668(3′-G5). Cellular uptake study showed significantly increased 
uptake of CpG ODN after GQ structure formation. In addition, 1668(3′-G5) showed a slow decomposition in serum 
than 1668(5′-G5). These results indicated that the G-quadruplex formed by only one G-tract was a simple and 
efficient strategy for the delivery of CpG ODN to immune cells, and that addition of G-tract to 3′-end was effective 
in obtaining monomeric GQ structured CpG ODN with high biological stability and high immunostimulatory 
activity. 
 
Chapter 2  Development of Mannose-modified Nanostructured DNA for Targeted Delivery of CpG ODN 
to Antigen-presenting Cells 
    Mannose receptor (MR), primarily expressed on the surface of APCs, mediated endocytosis has been studied 
to achieve cell-specific drug delivery. Therefore, the applicant selected a hexapodna, a polypodna with six pods, 
and designed a mannose-modified hexapodna to efficiently deliver CpG ODN to the APCs. The modification 
strategy was to load the mannose-modified CpG1668 (Man-CpG1668) onto the CG sequence-free hexapodna. 
Firstly, a mannose motif with a 5 carbons linker, which aimed at increasing its interaction with receptor, was 
synthesized by 4 steps. Then, CpG1668 with phosphodiester backbone was successfully modified by the mannose 
motif at 5′-end to give mannose-modified CpG1668 (Man-CpG1668). Man-CpG1668 loaded hexapodna (Man-
  
CpG1668/Hexapodna) was prepared by annealing all ODNs in one-pot and was obtained with high yield. The 
melting temperature analysis showed mannose modification hardly changed the thermal stability. Man-
CpG1668/hexapodna induced greater TNF-α release from TLR9- and MR-positive mouse peritoneal macrophages 
than CpG1668/hexapodna. These results indicate that the mannose-modified hexapodna is suitable for the delivery 
of CpG ODN to TLR9-positive immune cells. 
 
Chapter 3  Development of Mannose-modified G-quadruplex Structured CpG ODN for Targeted Delivery 
to Antigen-presenting Cells 
    To further expand the capability of GQ structured CpG ODN, the applicant attempted to construct a mannose-
modified GQ structured CpG ODN. Initially, 1668(5′-G5) and 1668(3′-G5) were successfully modified at 3′-end 
[1668(5′-G5, 3′-Man)] and 5′-end [1668(5′-Man, 3′-G5)] separately by the mannose motif which was synthesized 
in Chapter 2. However, these two modified sequences failed to form the GQ structure due to the steric hindrance 
and repulsion from the long hydrophobic linker. Therefore, 1668(5′-G5) and 1668(3′-G5) were directly modified by 
α-D-mannopyranosylphenyl isothiocyanate and they could be successfully converted to GQ structures. After 
mannose modification, 1668(5′-G5, 3′-Man) induced higher secretion of TNF-α from mouse peritoneal 
macrophages than unmodified and mannose modified 1668(5′-Man, 3′-G5). These results suggested that the 
immunostimulatory activity of GQ structured CpG ODN could be further increased by mannose modification and 
indicated the higher density of mannose motif might be necessary to increase the interaction of CpG ODN with 




認める。また、令和 2年 2月 14日、論文内容とそれに関連した事項について試問を行った結
果、合格と認めた。 
 
 
